TissGDB
Tissglogo

Home

Download

 Statistics

 Landscape

Help

Contact

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

bullet point

TissGeneSummary

bullet point

TissGeneExp

bullet point

TissGene-miRNA

bullet point

TissGeneMut: TissGeneSNV, TissGeneCNV, and TissGeneFusions

bullet point

TissGeneNet

bullet point

TissGeneProg

bullet point

TissGeneClin: TissGeneDrug and TissGeneDisease

TissGeneSummary for FEZF1
check button Gene summary
Basic gene informationGene symbolFEZF1
Gene nameFEZ family zinc finger 1
SynonymsFEZ|HH22|ZNF312B
CytomapUCSC genome browser: 7q31.32
Type of geneprotein-coding
RefGenesNM_001024613.3,
NM_001160264.2,
Descriptionfez family zinc finger protein 1zinc finger protein 312B
Modification date20141207
dbXrefs MIM : 613301
HGNC : HGNC
Ensembl : ENSG00000128610
HPRD : 18614
Vega : OTTHUMG00000157091
ProteinUniProt:
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_FEZF1
BioGPS: 389549
PathwayNCI Pathway Interaction Database: FEZF1
KEGG: FEZF1
REACTOME: FEZF1
Pathway Commons: FEZF1
ContextiHOP: FEZF1
ligand binding site mutation search in PubMed: FEZF1
UCL Cancer Institute: FEZF1
Assigned class in TissGDB*C
Included tissue-specific gene expression resourcesHPA,GTEx
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx)Testis
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA)TGCT
Reference showing the relevant tissue of FEZF1
Description by TissGene annotations
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C.

check button Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO termPubMed ID


Top
TissGeneExp for FEZF1

check button Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
gene exp


check button Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01)
gene isoform exp


check button Gene expressions across normal tissues of GTEx data
(GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct)
- Here, we shows the matched tissue types only among our 28 cancer types.
normal gene exp


check button Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
DEG exp

- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05)
Cancer typeMean(exp) in tumorMean(exp) in matched normalLog2FCP-val.FDR
COAD-0.491721766-3.1296025352.6378807691.50E-056.60E-05
LUSC0.364596711-2.3844268182.7490235297.90E-102.73E-09
LUAD0.258037651-2.4750623492.73313.47E-122.57E-11
STAD1.157442177-2.7002015733.857643751.63E-091.22E-07
BLCA-1.184406179-2.6685219681.4841157890.005040.026614218
HNSC-1.288505934-2.6076384921.3191325580.0008130.002836047


Top
TissGene-miRNA for FEZF1

check button Significantly anti-correlated miRNAs of TissGene across 28 cancer types
(Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016)
(TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21)
(TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16)
(Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25))
Cancer typemiRNA idmiRNA accessionP-val.Coeff.# samples
UCShsa-miR-369-3pMIMAT00007210.049-0.2756


Top
TissGeneMut for FEZF1
TissGeneSNV for FEZF1

check button nsSNV counts per each loci.
Different colors of circles represent different cancer types. Circle size denotes number of samples.
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)

* Click on the image to enlarge it in a new window.
bullet point


check button Somatic nucleotide variants of TissGene across 28 cancer types
(X-axis: cancer type and Y-axis: % of mutated samples)
The numbers in parentheses are numbers of samples with mutation (nsSNVs).
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)
SNV distribution

- nsSNVs sorted by frequency.
AAchangeCancer type# samples
p.N375SREAD1
p.A234VREAD1
p.P257LSKCM1
p.G215AHNSC1
p.T311MPRAD1
p.T401ASTAD1
p.Q225PHNSC1
p.G89RSKCM1
p.G435ALUSC1
p.P399LSKCM1
p.S116RKIRP1
p.L67HLUAD1
p.C262FHNSC1
p.I309FMESO1
p.D396NBLCA1
p.F325CCOAD1
p.S222CBLCA1
p.P76SSKCM1
p.A114TSARC1
p.P172SLUAD1
p.K62RHNSC1
p.A430TLUAD1
p.S329FHNSC1
p.H191QOV1
p.G473DLUSC1
p.A324SBLCA1
p.E313KSKCM1
p.P429SUCEC1
p.Y229*LUAD1
p.G20CCOAD1
p.E210QBLCA1
p.S64YLGG1
p.N164KTGCT1
p.G59ESKCM1
p.P457SUCEC1
p.D247ESKCM1
p.M279KBLCA1
p.H306NSARC1
p.D424NBLCA1
p.R250*LUSC1
p.N395KHNSC1
p.D414NBLCA1
p.G251DHNSC1
p.A271VPRAD1
p.Q225HOV1
p.E239KSKCM1
p.P403LHNSC1
p.T432KLUAD1
p.V216LSARC1
p.P79HSTAD1
p.S328IACC1
p.R96QSTAD1
p.I71VPAAD1
p.C410XESCA1
p.A156DUCEC1
p.G54ESKCM1
p.E232KSKCM1
p.P76LSKCM1
p.R420CSKCM1
p.R286KGBM1
p.A208VHNSC1
p.E210DTHYM1
p.A108ELUSC1
p.R96QHNSC1
p.K87RPAAD1
p.G296SSKCM1
p.P49SSKCM1
p.P441QLUAD1


Top
TissGeneCNV for FEZF1

check button Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples)
(TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16)
CNV


Top
TissGeneFusions for FEZF1

check button Fusion genes including TissGene
(ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01)
DatabaseSrcCancer typeSampleFusion geneORF5'-gene BP3'-gene BP


Top
TissGeneNet for FEZF1

check button Co-expressed gene networks based on protein-protein interaction data (CePIN)
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(PINA2 ppi data)
BRCA (tumor)BRCA (normal)
FEZF1, SP1 (tumor)FEZF1, SP1 (normal)
bullet pointbullet point
COAD (tumor)COAD (normal)
FEZF1, SP1 (tumor)FEZF1, SP1 (normal)
bullet pointbullet point
HNSC (tumor)HNSC (normal)
FEZF1, SP1 (tumor)FEZF1, SP1 (normal)
bullet pointbullet point
KICH (tumor)KICH (normal)
FEZF1, SP1 (tumor)FEZF1, SP1 (normal)
bullet pointbullet point
KIRC (tumor)KIRC (normal)
FEZF1, SP1 (tumor)FEZF1, SP1 (normal)
bullet pointbullet point
KIRP (tumor)KIRP (normal)
FEZF1, SP1 (tumor)FEZF1, SP1 (normal)
bullet pointbullet point
LIHC (tumor)LIHC (normal)
FEZF1, SP1 (tumor)FEZF1, SP1 (normal)
bullet pointbullet point
LUAD (tumor)LUAD (normal)
FEZF1, SP1 (tumor)FEZF1, SP1 (normal)
bullet pointbullet point
LUSC (tumor)LUSC (normal)
FEZF1, SP1 (tumor)FEZF1, SP1 (normal)
bullet pointbullet point
PRAD (tumor)PRAD (normal)
FEZF1, SP1 (tumor)FEZF1, SP1 (normal)
bullet pointbullet point
STAD (tumor)STAD (normal)
FEZF1, SP1 (tumor)FEZF1, SP1 (normal)
bullet pointbullet point
THCA (tumor)THCA (normal)
FEZF1, SP1 (tumor)FEZF1, SP1 (normal)
bullet pointbullet point


Top
TissGeneProg for FEZF1

check button Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image to enlarge it in a new window.
survival 1

check button Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 2

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 3

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 4

Top
TissGeneClin for FEZF1
TissGeneDrug for FEZF1

check button Drug information targeting TissGene
(DrugBank Version 5.0.6, 2017-04-01)
DrugBank IDDrug nameDrug activityDrug typeDrug status


Top
TissGeneDisease for FEZF1

check button Disease information associated with TissGene
(DisGeNet, 2016-06-01)
Disease IDDisease name# pubmedsSource
umls:C0024623Malignant neoplasm of stomach2BeFree
umls:C0699791Stomach Carcinoma2BeFree
umls:C0004352Autistic Disorder1GAD
umls:C0027627Neoplasm Metastasis1BeFree
umls:C0038356Stomach Neoplasms1BeFree
umls:C0162809Kallmann Syndrome1BeFree,ORPHANET
umls:C0178874Tumor Progression1BeFree
umls:C0596263Carcinogenesis1BeFree
umls:C4014988HYPOGONADOTROPIC HYPOGONADISM 22 WITH OR WITHOUT ANOSMIA1UNIPROT